Literature DB >> 23448726

Improved pregnancy outcomes in women exposed to malaria with high antibody levels against Plasmodium falciparum.

Alfredo Mayor1, Urwashi Kumar, Azucena Bardají, Pankaj Gupta, Alfons Jiménez, Amel Hamad, Betuel Sigaúque, Bijender Singh, Llorenç Quintó, Sanjeev Kumar, Puneet K Gupta, Virander S Chauhan, Carlota Dobaño, Pedro L Alonso, Clara Menéndez, Chetan E Chitnis.   

Abstract

BACKGROUND: Antibodies against VAR2CSA, the Plasmodium falciparum variant surface antigen that binds placental chondroitin sulfate A, have been suggested to mediate protection against malaria in pregnancy but also to be markers of infection. Here, we aimed to identify clinically relevant antibody responses, taking into consideration variations in parasite exposure and human immunodeficiency virus type 1 (HIV) infection status.
METHODS: Levels of immunoglobulin G (IgG) against placental and pediatric isolates, VAR2CSA (DBL2X, DBL3X, DBL5ε, and DBL6ε domains), and other blood-stage antigens (DBLγ, DBLα, MSP119, AMA1, and EBA175) were measured in plasma specimens from 293 pregnant Mozambican women at delivery. Associations between antibody responses, factors influencing malaria exposure, HIV infection status, and pregnancy outcomes were assessed.
RESULTS: Maternal antibodies were affected by placental infection, parity, season, and neighborhood of residence. HIV infection modified these associations and attenuated the parity-dependent increase in IgG level. High levels of antibody against AMA1, DBL3X, DBL6ε, placental isolates, and pediatric isolates were associated with increased weight and gestational age of newborns (P ≤ .036) among women with malaria episodes during pregnancy.
CONCLUSIONS: Antiparasite IgGs in women at delivery are affected by HIV infection, as well as by variations in the exposure to P. falciparum. Heterogeneity of malaria transmission needs to be considered to identify IgGs against VAR2CSA and other parasite antigens associated with improved pregnancy outcomes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23448726     DOI: 10.1093/infdis/jit083

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  23 in total

1.  Association of Antibodies to VAR2CSA and Merozoite Antigens with Pregnancy Outcomes in Women Living in Yaoundé, Cameroon.

Authors:  Yukie M Lloyd; Rui Fang; Naveen Bobbili; Koko Vanda; Elise Ngati; Maria J Sanchez-Quintero; Ali Salanti; John J Chen; Rose G F Leke; Diane W Taylor
Journal:  Infect Immun       Date:  2018-08-22       Impact factor: 3.441

Review 2.  Targeting Pregnant Women for Malaria Surveillance.

Authors:  Alfredo Mayor; Clara Menéndez; Patrick G T Walker
Journal:  Trends Parasitol       Date:  2019-08-05

Review 3.  Malaria and immunity during pregnancy and postpartum: a tale of two species.

Authors:  A R D McLean; R Ataide; J A Simpson; J G Beeson; F J I Fowkes
Journal:  Parasitology       Date:  2015-03-03       Impact factor: 3.234

4.  CD14(hi)CD16+ monocytes phagocytose antibody-opsonised Plasmodium falciparum infected erythrocytes more efficiently than other monocyte subsets, and require CD16 and complement to do so.

Authors:  Jingling Zhou; Gaoqian Feng; James Beeson; P Mark Hogarth; Stephen J Rogerson; Yan Yan; Anthony Jaworowski
Journal:  BMC Med       Date:  2015-07-07       Impact factor: 8.775

5.  Interactions between malaria and HIV infections in pregnant women: a first report of the magnitude, clinical and laboratory features, and predictive factors in Kinshasa, the Democratic Republic of Congo.

Authors:  Roger D Wumba; Josué Zanga; Michel N Aloni; Kennedy Mbanzulu; Aimé Kahindo; Madone N Mandina; Mathilde B Ekila; Oussama Mouri; Eric Kendjo
Journal:  Malar J       Date:  2015-02-18       Impact factor: 2.979

Review 6.  Designing a VAR2CSA-based vaccine to prevent placental malaria.

Authors:  Michal Fried; Patrick E Duffy
Journal:  Vaccine       Date:  2015-11-26       Impact factor: 3.641

7.  Association between malaria immunity and pregnancy outcomes among Malawian pregnant women receiving nutrient supplementation.

Authors:  Upeksha P Chandrasiri; Freya J I Fowkes; James G Beeson; Jack S Richards; Steve Kamiza; Kenneth Maleta; Per Ashorn; Stephen J Rogerson
Journal:  Malar J       Date:  2016-11-09       Impact factor: 2.979

8.  High Antibodies to VAR2CSA in Response to Malaria Infection Are Associated With Improved Birthweight in a Longitudinal Study of Pregnant Women.

Authors:  Alistair R D McLean; D Herbert Opi; Danielle I Stanisic; Julia C Cutts; Gaoqian Feng; Alice Ura; Ivo Mueller; Stephen J Rogerson; James G Beeson; Freya J I Fowkes
Journal:  Front Immunol       Date:  2021-06-16       Impact factor: 7.561

9.  Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial.

Authors:  Raquel González; Meghna Desai; Eusebio Macete; Peter Ouma; Mwaka A Kakolwa; Salim Abdulla; John J Aponte; Helder Bulo; Abdunoor M Kabanywanyi; Abraham Katana; Sonia Maculuve; Alfredo Mayor; Arsenio Nhacolo; Kephas Otieno; Golbahar Pahlavan; María Rupérez; Esperança Sevene; Laurence Slutsker; Anifa Vala; John Williamsom; Clara Menéndez
Journal:  PLoS Med       Date:  2014-09-23       Impact factor: 11.069

10.  Malaria in pregnant women living in areas of low transmission on the southeast Brazilian Coast: molecular diagnosis and humoural immunity profile.

Authors:  Angélica Domingues Hristov; Maria Carmen Arroyo Sanchez; José Jarbas Bittencourt Ferreira; Giselle Fernandes Maciel de Castro Lima; Juliana Inoue; Maria de Jesus Costa-Nascimento; Arianni Rondelli Sanchez; Eduardo Milton Ramos-Sanchez; Silvia Maria Di Santi
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-12-09       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.